Meso Scale Technologies LLC is a biotechnology company. It provides chemiluminescence based detection technologies and products. The company was founded by Jacob N. Wohlstadter in1995 and is headquartered in Wilmington, DE.

Promega Contributing to the prevention, healing and more. Founded in 1978, which began with the production of enzymes for research, has evolved into a catalog of over 2,000 products for a wide range of applications, including basic research, drug discovery, forensics, paternity testing and diagnosis clinician.

Develops pharmaceutical products

Hamamatsu Photonics KK engages in the manufacture and sale of imaging and analyzing systems, photomultiplier tubes, imaging devices, light sources, and opto-semiconductors. It operates through the following segments: Electron Tube, Opto-semiconductor, Imaging and Measurement Instruments, and Others. The Electron Tube segment produces photomultiplier tubes, light sources, and imaging devices. The Opto-semiconductor segment offers optical semiconductor devices. The Imaging and Measurement Instruments segment deals with image processing and measurement systems. The Others segment includes semiconductor lasers and hotel businesses. The company was founded by Heihachiro Horiuchi in September 1948 and is headquartered in Hamamatsu, Japan.

Henan Jidan Biotechnology Co., Ltd., established on 2015-07-09, Business scope includes biomedical technology development,technical consulting,technology transfer;Health Information Consultation(no medical,Diagnosis and treatment items);Wholesale and retail:electronic product,Class of medical equipment,Class II,Three types of technology development,production and sales.

Quantum-Si is focused on revolutionizing the growing field of proteomics. The company’s suite of technologies are powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.

LJL is developing and marketing proprietary technologies and products to accelerate and enhance the drug discovery process. LJL's proprietary integrated technology platform is comprised of instrumentation and fluorescence-based and other assay technologies designed to provide a flexible solution to the current and evolving HTS requirements of drug discovery laboratories. The drug discovery process involves several stages including target identification, compound synthesis, assay development, screening and lead optimization.

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing, and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. According to the World Health Organization, WHO, more than 700 million cases of psychiatric and neurological disorders are reported every year. These are serious and life-threatening diseases that affect the quality of life of the patients as well as of their relatives. As these diseases also involve major socio-economic costs, it is imperative for the general society that new and innovative pharmaceuticals are developed. Over the past 50 years, new pharmaceuticals have revolutionized the treatment options, but there remains a large unmet need for new and innovative therapeutics. Focus on R&D is the most important pillar in Lundbeck’s ambition to improve treatment for people living with psychiatric and neurological disorders. We are specialists in our area and have research facilities in Denmark and China, and more than 1,000 employees work in our R&D units. We cooperate closely with strategic partners all over the world, ensuring the best possible foundation for innovation and the development of new treatment solutions. Lundbeck employs approximately 5,300 people worldwide, 1,700 of whom are based in Denmark. We have employees in 55 countries, and our products are registered in more than 100 countries. We have production facilities in China, Denmark, France and Italy and research centers in Denmark and China.

Hitachi High-Tech America, Inc., a subsidiary of Hitachi Ltd., is an American company located in Schaumburg, IL, that manufactures semiconductor manufacturing equipment, industrial equipment & electronic devices.

Autobio Diagnostics is a company mainly engaged in development, manufacture and sales of diagnostics products.

Toyo Ink SC Holdings Co., Ltd. engages in the strategic planning and management of its group companies. Its operations are carried out through the following business segments: Colorants and Functional Materials, Polymers and Coatings, Packaging Materials, Printing and Information, and Others. The Colorants and Functional Materials segment offers organic pigments, processed pigments, plastic colorants, and materials for color filters. The Polymers and Coatings segment produces and markets can paints, resins, adhesives, coating materials, natural extracts, and medical products. The Packaging Materials segment deals with gravure inks, flexo inks, and gravure cylinder making systems. The Printing and Information segment manufactures and sells offset inks, metal decorative inks, printers, printing materials, and prepress. The Others segment includes provision of services and sale of raw materials. The company was founded by Kamataro Kobayashi in January 1896 and is headquartered in Tokyo, Japan.

Addcare manufactures medical testing equipment products and provides complete sets of automated testing solutions. It has a product R&D and manufacturing system, and an automated R&D team and its products have independent intellectual property rights. The company was established in August 2006 and is headquartered in Yantai City, Shandong Province, China.

Prolume is a biotechnology company whose core business is based upon newly discovered genes from deep water marine bioluminescent organisms. This has broad applications for biomedical research, drug discovery, and entertainment.

Shenyang Yilu Biotechnology Co., Ltd., established on 2016-12-23, Business scope includes licensed projects:Production of Class II Medical Devices,Production of Class III Medical Devices,Class III medical device business,Internet Information Service for Medical Devices,Technology Import and Export,Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Sales of Class II Medical Devices,Production of Class I Medical Devices,Sales of Class I Medical Devices,Domestic trade agent,software development,software sales,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Medical equipment rental,Wholesale of electronic components,Metal Products Sales,Medical Research and Experimental Development,Chemical product sales(No licensed chemical products),Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals),Specialty Chemicals Sales(Free of Hazardous Chemicals),Biochemical product technology research and development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

BioVeris is a healthcare company that provides diagnostic services. The company develops and commercialize technologies in diagnostics and vaccinology. The company provides electrochemiluminescence and immunochemistry services. It also develops a range of energy light fixture products that include a set of fluorescent bulbs in a box with a diffusing display for seasonal affective disorders, and acne and skin conditions. In addition, the company provides information in the areas of automation, biosecurity, diagnostics, instrumentation, medical machinery, and vaccinology.

Yantai Xingqi Medical Laboratory Co., Ltd., established on 2019-10-14, Business scope includes clinical body fluid testing,clinical blood test,Clinical Microbiology Testing,Clinical Biochemical Testing,clinical immunology testing,clinical serological testing,clinicopathological diagnosis,Clinical Cytomolecular Genetic Testing,Clinical gene amplification experiments,Medical laboratory technical consultation.(No country restrictions,Prohibited items;Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hunan Feike Biotechnology Co., Ltd., established on 2020-03-02, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Bidding agency service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).